BSX Trading Analysis - 10/29/2026 02:58 PM — TRU-SENTIMENT

News Headlines & Context

Boston Scientific (BSX) recently closed a major acquisition in the electrophysiology space, expanding its portfolio of cardiac mapping and ablation products. The company also presented positive long-term clinical data for its Watchman left-atrial appendage closure device at a major cardiology conference. Analysts noted softness in certain MedTech end-markets, though BSX guidance remained intact for the fiscal year. A broad MedTech sector pullback earlier in October pressured valuations across the group. The embedded price data shows a sharp drop on 2026-10-28 with a low of $39.57 (also the 52-week low in fundamentals), suggesting the news flow coincided with a significant de-risking event in the stock.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data: Trailing P/E is 18.20 with trailing EPS of $2.48. Market cap is $61.03B with 1.45B shares outstanding. Dividend yield is 0.00% (no dividend rate). Beta is 0.57 (low market sensitivity). 52-week high is $105.65 and 52-week low is $39.57. Institutional ownership is 67.31%. Average volume is 17.64M. Historical volatility is 28.92%. Fiscal year end is 2025-12-01.

Data NOT available in fundamentals: revenue growth (null), profit margins (null), ROE (null), debt/equity (null), free cash flow (null), PEG ratio (null), forward P/E (null), target mean price (null), analyst consensus (null). The trailing P/E of 18.20 is the only valuation multiple provided; no sector peer comparison or PEG is possible from data. Fundamental picture shows moderate valuation with low beta and no yield, but key profitability and leverage metrics are absent. Price is at the 52-week low ($39.57 touched 2026-10-28), far below the $105.65 high, indicating a severe fundamental re-rating not explained by provided metrics. Fundamentals diverge from prior technical strength (price was $45.85 on 2026-10-22) and now align with bearish options flow.

Current Market Position

Current price per indicators: $42.62 (2026-10-28 close). Minute bars show 2026-10-28 09:30 open $41.95, low $39.57, close $40.85 first bar; by 2026-10-29 14:30 close $42.02. Recent daily action: 2026-10-27 close $44.95 → 2026-10-28 open $41.95, high $43.92, low $39.57, close $42.62 on volume 57.65M (far above 20d avg 12.67M). Intraday 2026-10-29: ranged $41.96–$42.07, low volatility, closing $42.02.

Technical Analysis

SMA alignment: Price $42.62 below SMA 5 ($44.93), SMA 20 ($43.71), SMA 50 ($45.10) → bearish stack. No golden cross; 5 < 20 < 50. RSI 53.14 neutral, no extreme. MACD -0.01 below signal -0.00, histogram -0.00 → marginally bearish momentum. Bollinger: price $42.62 between lower $41.02 and mid $43.71, no squeeze (width $5.38). 30d range high $46.55, low $39.57; price at 41.7% of range, near lower third.

True Sentiment Analysis (Delta 40-60 Options)

Options flow sentiment: Bearish. Call dollar vol $332,080 (15.6%), Put dollar vol $1,798,255 (84.4%), total $2,130,335. Contracts: 1,005 calls / 3,688 puts. Methodology: Delta 40-60 only, 50 of 878 analyzed (5.7% filter). Pure directional conviction heavily put-sided → near-term downside expectation.

Notable divergence: RSI neutral 53.14 and price stabilised $42.02 on 2026-10-29, but options flow screams bearish. Technical not yet confirmive of breakdown; sentiment leads.

Key Price Levels (Observational Only)